Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2019 Financial Results and Provides 2020 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Inspire Medical Systems (INSP) Tops Q4 EPS by 2c, Revenues Beat; Offers FY2) Revenue Guidance Above Consensus
February 25, 2020 4:50 PM ESTInspire Medical Systems (NYSE: INSP) reported Q4 EPS of ($0.38), $0.02 better than the analyst estimate of ($0.40). Revenue for the quarter came in at $26.9 million versus the consensus estimate of $23.84 million.
Recent Business Highlights
Achieved revenue of $26.9 million in the fourth quarter of 2019, a 62% increase over the same quarter last year, and revenue of $82.1 million in full year 2019, a 62% increase over full year 2018Provided full year 2020 revenue guidance in the range of $115 million to $119 million, representing growth of approximately 40% to 45% over full year 2019 revenue of... More